24092044|t|Quantitative regional validation of the visual rating scale for posterior cortical atrophy.
24092044|a|OBJECTIVES: Validate the four-point visual rating scale for posterior cortical atrophy (PCA) on magnetic resonance images (MRI) through quantitative grey matter (GM) volumetry and voxel-based morphometry (VBM) to justify its use in clinical practice. METHODS: Two hundred twenty-nine patients with probable Alzheimer's disease and 128 with subjective memory complaints underwent 3T MRI. PCA was rated according to the visual rating scale. GM volumes of six posterior structures and the total posterior region were extracted using IBASPM and compared among PCA groups. To determine which anatomical regions contributed most to the visual scores, we used binary logistic regression. VBM compared local GM density among groups. RESULTS: Patients were categorised according to their PCA scores: PCA-0 (n = 122), PCA-1 (n = 143), PCA-2 (n = 79), and PCA-3 (n = 13). All structures except the posterior cingulate differed significantly among groups. The inferior parietal gyrus volume discriminated the most between rating scale levels. VBM showed that PCA-1 had a lower GM volume than PCA-0 in the parietal region and other brain regions, whereas between PCA-1 and PCA-2/3 GM atrophy was mostly restricted to posterior regions. CONCLUSIONS: The visual PCA rating scale is quantitatively validated and reliably reflects GM atrophy in parietal regions, making it a valuable tool for the daily radiological assessment of dementia. KEY POINTS:   Visual rating scale reflects grey matter atrophy in posterior brain regions.   Different PCA scores corresponded well to different quantitative degrees of atrophy.   Inferior parietal gyrus volume influenced assessment based on the visual rating scale.   This simple visual rating scale makes it useful for radiological dementia assessment.
24092044	64	90	posterior cortical atrophy	Disease	MESH:D001284
24092044	152	178	posterior cortical atrophy	Disease	MESH:D001284
24092044	180	183	PCA	Disease	MESH:D001284
24092044	376	384	patients	Species	9606
24092044	399	418	Alzheimer's disease	Disease	MESH:D000544
24092044	443	460	memory complaints	Disease	MESH:D008569
24092044	479	482	PCA	Disease	MESH:D001284
24092044	648	651	PCA	Disease	MESH:D001284
24092044	826	834	Patients	Species	9606
24092044	871	874	PCA	Disease	MESH:D001284
24092044	883	886	PCA	Disease	MESH:D001284
24092044	900	903	PCA	Disease	MESH:D001284
24092044	917	920	PCA	Disease	MESH:D001284
24092044	937	940	PCA	Disease	MESH:D001284
24092044	1139	1142	PCA	Disease	MESH:D001284
24092044	1172	1175	PCA	Disease	MESH:D001284
24092044	1242	1245	PCA	Disease	MESH:D001284
24092044	1252	1255	PCA	Disease	MESH:D001284
24092044	1263	1270	atrophy	Disease	MESH:D001284
24092044	1339	1342	PCA	Disease	MESH:D001284
24092044	1409	1416	atrophy	Disease	MESH:D001284
24092044	1505	1513	dementia	Disease	MESH:D003704
24092044	1570	1577	atrophy	Disease	MESH:D001284
24092044	1618	1621	PCA	Disease	MESH:D001284
24092044	1684	1691	atrophy	Disease	MESH:D001284
24092044	1849	1857	dementia	Disease	MESH:D003704

